胎盘功能不全标志物用于评估早发型胎儿生长受限中非染色体遗传性疾病的风险
该回顾性分析纳入238例孤立性早发型胎儿生长受限病例,评估胎盘功能不全标志物对遗传异常风险的预测价值。7例(2.9%)检出遗传异常,sFlt-1/PlGF比值<38和PlGF≥100 pg/mL亚组的遗传异常患病率显著更高,而sFlt-1/PlGF比值≥38或PlGF<45 pg/mL的病例中未发现遗传异常。结论认为这些标志物可能有助于细化风险分层并优化全外显子组测序的使用。
要点
- sFlt-1/PlGF比值<38或PlGF≥100 pg/mL的早发型FGR病例遗传异常患病率显著高于总体队列。
- sFlt-1/PlGF比值≥38或PlGF<45 pg/mL的病例中未检出遗传异常。
- 单独胎儿多普勒或单独子宫动脉搏动指数不能识别遗传异常患病率显著不同的亚组。
核心结论
- 胎盘功能不全标志物尤其是sFlt-1/PlGF比值和PlGF水平可能有助于对孤立性早发型FGR的遗传异常进行细化风险分层,从而提供个体化产前咨询并优化WES的使用。
研究设计与样本
- 回顾性分析2016年2月至2022年12月西班牙巴塞罗那Vall d'Hebron大学医院前瞻性收集的病例,纳入孕20+0至28+6周诊断的孤立性早发型FGR单胎妊娠,共238例,通过染色体微阵列或全外显子组测序检测致病或可能致病性胎儿遗传异常。
诊断标准与关键数值
- 早发型FGR定义为估测胎儿体重≤第3百分位且诊断孕周≤28+6周;按sFlt-1/PlGF比值(<38 vs ≥38)、PlGF水平(<100 vs ≥100 pg/mL)、平均子宫动脉搏动指数(<第95百分位 vs ≥第95百分位)及胎儿多普勒(正常 vs 异常)分层;胎儿多普勒异常定义为脐动脉或静脉导管搏动指数>第95百分位,或大脑中动脉搏动指数或脑胎盘比<第5百分位。
临床应用与阅片要点
- 在孤立性早发型FGR病例中,可关注sFlt-1/PlGF比值和PlGF水平以辅助识别遗传异常风险较高的亚组;sFlt-1/PlGF比值<38和PlGF≥100 pg/mL亚组的遗传异常患病率显著高于总体队列,sFlt-1/PlGF比值≥38或PlGF<45 pg/mL的病例中未发现遗传异常;组合子宫动脉搏动指数和胎儿多普勒等标志物可能改善风险分层。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the value of placental insufficiency markers for estimating the risk of genetic anomalies in fetuses with isolated early-onset fetal growth restriction (FGR), defined as an estimated fetal weight ≤ 3rd percentile diagnosed ≤ 28 + 6 weeks' gestation.
METHODS: We performed a retrospective analysis of data collected prospectively from cases that attended Vall d'Hebron University Hospital, Barcelona, Spain, between February 2016 and December 2022. Singleton pregnancies diagnosed with isolated early-onset FGR between 20 + 0 and 28 + 6 weeks' gestation were eligible for inclusion. Cases in which a pathogenic or likely pathogenic fetal genetic abnormality was detected by chromosomal microarray (CMA) or whole-exome sequencing (WES) were identified. Cases were stratified by soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF) ratio (< 38 vs ≥ 38), PlGF level (< 100 vs ≥ 100 pg/mL), mean uterine artery (UtA) pulsatility index (PI) (< 95th vs ≥ 95th percentile) and fetal Doppler (normal vs abnormal) at the time of FGR diagnosis. Abnormal fetal Doppler was defined as a PI > 95th percentile in the umbilical artery or ductus venosus, or a middle cerebral artery PI or cerebroplacental ratio < 5th percentile. The prevalence of genetic anomalies in each subgroup was compared with that of the overall cohort. Additionally, combinations of markers of placental insufficiency were investigated to determine whether specific combinations could improve the ability to identify cases at risk of genetic anomaly.
RESULTS: In the total cohort of 238 cases of isolated early-onset FGR, seven (2.9%) cases of genetic anomaly were detected. Of these, 2/7 (28.6%) were detected by prenatal or postnatal CMA and 5/7 (71.4%) by postnatal WES. Fetal Doppler alone and UtA-PI alone did not identify subgroups with a significantly different prevalence of genetic abnormality compared with the overall cohort. In contrast, a sFlt-1/PlGF ratio < 38 and PlGF level ≥ 100 pg/mL defined subgroups with a significantly higher prevalence of genetic abnormality, while no genetic anomalies were found in cases with a sFlt-1/PlGF ratio ≥ 38 or PlGF level < 45 pg/mL. Furthermore, smaller subgroups combining markers of placental insufficiency identified cases at significantly higher or lower risk of FGR-related genetic anomaly.
CONCLUSIONS: Placental insufficiency markers, particularly the sFlt-1/PlGF ratio and PlGF level, may enable refined risk stratification of genetic anomalies in cases of isolated early-onset FGR, which could be used to provide individualized prenatal counseling and to optimize the use of WES. Furthermore, combining markers of placental insufficiency, such as UtA-PI and fetal Doppler, may improve risk stratification, potentially defining smaller subgroups with a higher prevalence of genetic anomalies, for which WES may provide greater diagnostic yield. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Armengol-Alsina M, Bonacina E, Dalmau M, et al. Placental insufficiency markers to assess the risk of non-chromosomal genetic conditions in early-onset fetal growth restriction. Ultrasound Obstet Gynecol. 2026. PMID: 41906976. doi:10.1002/uog.70211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。